RxDoctor Payments Data

Matthew Bruns

Nurse Practitioner · Bridgeton, MONPI 1447266333

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $90,509 of the $125,626 with a category attached, or 72.0%. Amgen accounts for 92.6% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $39,505, 3.3 times the $12,019 reported in 2021. Among nurse practitioner clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$125,626in general payments, 2019–2025

Across 320 payments — averaging $392.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$116K
  • Radius Health, Inc.$8K
  • AstraZeneca$721
  • UCB, Inc.$392
  • Kyowa Kirin, Inc.$338
  • KCI USA, Inc.$99
  • plus $163 from 2 others

What the payments were for

  • Consulting fees$9,2987%
  • Speaking & faculty fees$90,50972%
  • Travel & lodging$17,98914%
  • Food & beverage$7,8306%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen268$116,280
Radius Health, Inc.33$7,634
AstraZeneca6$721
UCB, Inc.7$392
Kyowa Kirin, Inc.3$338
KCI USA, Inc.1$99
Stryker1$96
Medtronic1$68

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$125,626 in reported general payments places this provider in the 95th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri

Medicare billing

Part B allowed, 2024
$19,274
Medicare patients
217
Services billed
374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TymlosAbaloparatide23$60,652
ForteoTeriparatide12$48,410
Alendronate Sodium172$844
Celecoxib23$328
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$181
Diclofenac Sodium14$171
Methylprednisolone11$74
Meloxicam27$15

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Radius Health, Inc.Tymlos$7,634$60,65223 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,898 nurse practitioner providers in Missouri.

Other nurse practitioner in Bridgeton

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →